|
FDXACB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.29619999867626E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92270000000305E-05 |
| Normal-vs-Stage2 |
4.794400E-02 |
| Normal-vs-Stage3 |
8.74179999499347E-08 |
| Normal-vs-Stage4 |
3.75480000425199E-08 |
| Stage1-vs-Stage2 |
8.438800E-01 |
| Stage1-vs-Stage3 |
1.902240E-02 |
| Stage1-vs-Stage4 |
9.723100E-03 |
| Stage2-vs-Stage3 |
4.426600E-01 |
| Stage2-vs-Stage4 |
3.187000E-01 |
| Stage3-vs-Stage4 |
6.243200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14480000035222E-07 |
| Normal-vs-AfricanAmerican |
3.647200E-04 |
| Normal-vs-Asian |
3.268400E-02 |
| Caucasian-vs-AfricanAmerican |
7.938600E-01 |
| Caucasian-vs-Asian |
9.056400E-01 |
| AfricanAmerican-vs-Asian |
9.883200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0654000015542E-08 |
| Normal-vs-Female |
7.431000E-04 |
| Male-vs-Female |
1.162490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.241340E-03 |
| Normal-vs-Age(41-60Yrs) |
1.94095999999089E-05 |
| Normal-vs-Age(61-80Yrs) |
1.12070000002351E-06 |
| Normal-vs-Age(81-100Yrs) |
5.81629999999445E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.239600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.254600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.903000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.940200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.808840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.534220E-02 |
| Normal-vs-Grade 2 |
6.400000E-03 |
| Normal-vs-Grade 3 |
5.24950083402587E-11 |
| Normal-vs-Grade 4 |
8.78450000518782E-08 |
| Grade 1-vs-Grade 2 |
5.120800E-01 |
| Grade 1-vs-Grade 3 |
4.249200E-01 |
| Grade 1-vs-Grade 4 |
3.822200E-01 |
| Grade 2-vs-Grade 3 |
7.66490000000397E-05 |
| Grade 2-vs-Grade 4 |
1.103260E-03 |
| Grade 3-vs-Grade 4 |
5.785800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.201600E-03 |
| Normal-vs-ccB subtype |
4.73789999455576E-08 |
| ccA subtype-vs-ccB subtype |
9.160800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13089999997928E-06 |
| Normal-vs-N1 |
2.714000E-02 |
| N0-vs-N1 |
5.027000E-01 |
|
|
